Indofarma Tbk. vs Rans Entertainmen Indonesia Tbk — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Rans Entertainmen Indonesia Tbk trades at Rp200 (market cap 2.57T, 67.92M 24h volume). The key difference: Rans Entertainmen Indonesia Tbk is far larger — about 6.6× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | RANS | |
|---|---|---|
Market Cap | 390.51B | 2.57T |
Volume | — | 67.92M |
Lot | — | 679.19K |
Turnover | — | 13.51B |
Average Price | — | 198.89 |
Value | — | 13.51B |
Indicative Equilibrium Price | — | 200 |
Indicative Equilibrium Volume | — | 4.66K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT. Rans Entertainmen Indonesia Tbk. (the Company) was established with Deed No. 04 on October 18, 2016, which was made before Raden Mas Dendy Subangil S.H., M.Kn., under the name of PT RNR Film Internasional. The Company started its commercial operations in 2018. The Company does not have a parent entity, the ultimate controlling party is Raffi Farid Ahmad as the Companys shareholder.
Read more on RANS →